Brief: Diamyd Medical Gets Patent For Insulin Antigen Treatment

Diamyd Medical AB

03/10/2025 13:41

Oct 3 (Reuters) - Diamyd Medical AB DMYDb.ST:

HONG KONG GRANTS PRECISION MEDICINE PATENT TO DIAMYD MEDICAL FOR INSULIN ANTIGEN TREATMENT IN TYPE 1 DIABETES

PATENT VALID UNTIL 2038, STRENGTHENS GLOBAL IP PORTFOLIO

Source text: ID:nWkr64Bk3f

Further company coverage: [DMYDb.ST]

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))